Navidea Biopharmaceuticals to Present at the Jefferies and Co. 2013 Global Healthcare Conference

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that Thomas Tulip, President and Chief Business Officer, will participate at the Jefferies 2013 Global Healthcare Conference on June 3-6, 2013 at the Grand Hyatt in New York City, NY. Dr. Tulip will provide an update of the Company and its development programs on Tuesday, June 4, 2013 at 2:30 PM EDT.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC